                               SEQUENCE LISTING

<110> YEAMAN, MICHAEL R.
 
<120> ANTIMICROBIAL FUSION PEPTIDES

<130> 0WVR-213137-WO

<140> PCT/US2016/035896
<141> 2016-06-03

<150> 62/171,868
<151> 2015-06-05

<160> 17    

<170> PatentIn version 3.5

<210> 1
<211> 39
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 1
Cys Pro Thr Ala Gln Leu Ile Ala Thr Leu Lys Asn Gly Arg Lys Ile 
1               5                   10                  15      


Cys Leu Asp Leu Gln Ala Leu Tyr Lys Lys Phe Lys Lys Lys Leu Leu 
            20                  25                  30          


Lys Ser Leu Lys Arg Leu Gly 
        35                  


<210> 2
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 2
Cys Pro Thr Ala Gln Leu Ile Ala Thr Leu Lys Asn Gly Arg Lys Ile 
1               5                   10                  15      


Cys Leu Asp Leu Gln 
            20      


<210> 3
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 3
Ala Leu Tyr Lys Lys Phe Lys Lys Lys Leu Leu Lys Ser Leu Lys Arg 
1               5                   10                  15      


Leu Gly 
        


<210> 4
<211> 22
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 4
Cys Pro Thr Ala Gln Leu Ile Ala Thr Leu Lys Asn Gly Arg Lys Ile 
1               5                   10                  15      


Cys Leu Asp Leu Gln Pro 
            20          


<210> 5
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 5
Cys Pro Thr Ala Gln Leu Ile Ala Thr Leu Lys Asn Gly Arg Lys Ile 
1               5                   10                  15      


Cys Leu Asp Leu Gln Ala Pro 
            20              


<210> 6
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 6
Cys Pro Thr Ala Gln Leu Ile Ala Thr Leu Lys Asn Gly Pro Lys Ile 
1               5                   10                  15      


Cys Leu Asp Leu Gln 
            20      


<210> 7
<211> 22
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 7
Cys Pro Thr Ala Gln Leu Ile Ala Thr Leu Lys Asn Gly Arg Lys Ile 
1               5                   10                  15      


Cys Leu Asp Leu Gln Ala 
            20          


<210> 8
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 8
Cys Pro Thr Ala Gln Leu Ile Ala Thr Leu Lys Asn Gly Arg Lys Ile 
1               5                   10                  15      


Pro Leu Asp Leu Gln 
            20      


<210> 9
<211> 19
<212> PRT
<213> Homo sapiens

<400> 9
Lys Glu Asn Trp Val Gln Arg Val Val Glu Lys Phe Leu Lys Arg Ala 
1               5                   10                  15      


Glu Asn Ser 
            


<210> 10
<211> 38
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 10
Ala Asn Thr Glu Ile Ile Val Lys Leu Ser Asp Gly Arg Glu Leu Cys 
1               5                   10                  15      


Leu Asp Pro Lys Glu Asn Trp Val Gln Arg Val Val Glu Lys Phe Leu 
            20                  25                  30          


Lys Arg Ala Glu Asn Ser 
        35              


<210> 11
<211> 32
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: 
      Rabbit polypeptide

<400> 11
Asn Leu Ile Ala Thr Lys Lys Asn Gly Arg Lys Leu Cys Leu Asp Leu 
1               5                   10                  15      


Gln Ala Ala Leu Tyr Lys Lys Lys Ile Ile Lys Lys Leu Leu Glu Ser 
            20                  25                  30          


<210> 12
<211> 19
<212> PRT
<213> Homo sapiens

<400> 12
Ala Asn Thr Glu Ile Ile Val Lys Leu Ser Asp Gly Arg Glu Leu Cys 
1               5                   10                  15      


Leu Asp Pro 
            


<210> 13
<211> 40
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 13
Cys Pro Thr Ala Gln Leu Ile Ala Thr Leu Lys Asn Gly Arg Lys Ile 
1               5                   10                  15      


Cys Leu Asp Leu Gln Ala Ala Leu Tyr Lys Lys Phe Lys Lys Lys Leu 
            20                  25                  30          


Leu Lys Ser Leu Lys Arg Leu Gly 
        35                  40  


<210> 14
<211> 40
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 14
Cys Pro Thr Ala Gln Leu Ile Ala Thr Leu Lys Asn Gly Arg Lys Ile 
1               5                   10                  15      


Cys Leu Asp Leu Gln Pro Ala Leu Tyr Lys Lys Phe Lys Lys Lys Leu 
            20                  25                  30          


Leu Lys Ser Leu Lys Arg Leu Gly 
        35                  40  


<210> 15
<211> 39
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 15
Cys Pro Thr Ala Gln Leu Ile Ala Thr Leu Lys Asn Gly Arg Lys Ile 
1               5                   10                  15      


Pro Leu Asp Leu Gln Ala Leu Tyr Lys Lys Phe Lys Lys Lys Leu Leu 
            20                  25                  30          


Lys Ser Leu Lys Arg Leu Gly 
        35                  


<210> 16
<211> 41
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 16
Cys Pro Thr Ala Gln Leu Ile Ala Thr Leu Lys Asn Gly Arg Lys Ile 
1               5                   10                  15      


Cys Leu Asp Leu Gln Ala Pro Ala Leu Tyr Lys Lys Phe Lys Lys Lys 
            20                  25                  30          


Leu Leu Lys Ser Leu Lys Arg Leu Gly 
        35                  40      


<210> 17
<211> 39
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 17
Cys Pro Thr Ala Gln Leu Ile Ala Thr Leu Lys Asn Gly Pro Lys Ile 
1               5                   10                  15      


Cys Leu Asp Leu Gln Ala Leu Tyr Lys Lys Phe Lys Lys Lys Leu Leu 
            20                  25                  30          


Lys Ser Leu Lys Arg Leu Gly 
        35                  
